PMDA drug package insert
アイベータ配合点眼液（添加剤にベンザルコニウム塩化物を含む、使用期限2028年5月まで）
PMDA Prescription drug · 千寿製薬株式会社 · package insert Sep 3, 2025
Key facts
| Brand names | アイベータ配合点眼液（添加剤にベンザルコニウム塩化物を含む、使用期限2028年5月まで） |
|---|---|
| Nonproprietary names | ブリモニジン酒石酸塩・チモロールマレイン酸塩 |
| Companies | 製造販売元／千寿製薬株式会社, 販売／武田薬品工業株式会社, 提携／大塚製薬株式会社 |
| Product type | Prescription drug |
| Therapeutic category | α2作動薬/β遮断薬配合剤 緑内障・高眼圧症治療剤 |
| Therapeutic category codes | 871319 |
| YJ codes | 1319824Q1020 |
| Approval numbers | 30100AMX00243 |
| Package insert edition | 第4版 |
| Package insert date | Sep 3, 2025 |
| PMDA document key | 380086_1319824Q1020_3 |
| PMDA company code | 380086 |
At a glance
- 1–9 Package insert revisions
- 10–99 Related PMDA documents
- None Safety communications
- Yes PMDA review report published
- Yes Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: